Recognition June 2022

Dublin joins FDA committee

Sascha Dublin, MD, PhD, is now a member of the Drug Safety and Risk Management Advisory Committee for the U.S. Food and Drug Administration (FDA). Dublin is a KPWHRI senior investigator and physician with the Washington Permanente Medical Group. As an FDA committee member, she will contribute to decisions about the safety and regulation of approved medications, advising the Commissioner of Food and Drugs on risk management, risk communication, and quantitative evaluation of products for which the FDA has regulatory responsibility.

Matson receives award for academic excellence

Tessa Matson, MPH, a research interventionist at Kaiser Permanente Washington Health Research Institute (KPWHRI), was recognized with the prestigious Gilbert S. Omenn Award for Academic Excellence. The honor is from the University of Washington School of Public Health, where Matson is a PhD student, studying screening and assessment tools for substance use disorders. Her mentors include KPWHRI Senior Investigator Kathy Bradley, MD, MPH, and Associate Investigator Joe Glass, PhD, MSW. The award recognizes impact on and commitment to public health. Matson already has 26 publications focusing on patient-centric, equitable care for mental health and addiction.

Larson joins National Academy of Sciences committee

Senior Investigator and former KPWHRI Executive Director Eric B. Larson, MD, MPH, was invited to serve a 3-year term on the Report Review Committee for the National Academy of Sciences. This committee oversees review of all reports from the National Academies to ensure their quality. All on the committee, including Larson, are members of the National Academy of Sciences, the National Academy of Engineering, or the National Academy of Medicine.

Yeung speaks about health economics and outcomes

Kai Yeung, PharmD, PhD, KPWHRI assistant investigator, was invited to speak at the global conference of the Professional Society for Health Economics and Outcomes Research (ISPOR) in Washington, DC, in May. Yeung, a pharmacist and pharmaceutical economist who studies patient medication-use behaviors, insurance design, and outcomes research, talked about his work on value-based pricing for prescription drugs in the U.S.

KPWHRI researchers contribute to clinician resource

The National Institute of Alcohol Abuse and Alcoholism developed a core resource on alcohol for clinicians. Several KPWHRI researchers served as reviewers and their research was cited to support the resource. Contributors from KPWHRI included Senior Investigator Kathy Bradley, MD, MPH, Associate Investigator Joe Glass, PhD, MSW, Evette Ludman, PhD (retired), and Affiliate Investigator Emily Williams, PhD, MPH. 

KPWHRI represented at ARM 2022

Representatives of KPWHRI presented at the June Annual Research Meeting of AcademyHealth in Washington, DC. Senior Investigator Paula Lozano, MD, MPH, spoke about work by the Center for Accelerating Care Transformation that was selected from a contest about challenges and strategies for embedded research in real-world settings. Also attending was Collaborative Researcher Jessica Mogk, MPH. Senior Investigator James Ralston, MD, MPH, presented about data dashboards to address social determinants of health in care. For the journal Health Services Research, Chris Tachibana, PhD, KPWHRI scientific editor, was on a panel about academic publishing. Affiliate Investigator Joshua Liao, MD, MSc, gave 2 talks on the impact of bundled payment models.

Lewis shares implementation science expertise

Senior Investigator Cara Lewis, PhD, recently gave 2 talks on best practices in implementation science:

Glass, Lapham, and Wartko speak about implementing substance use care

The College on Problems of Drug Dependence (CPDD)’s 84th Annual Scientific Meeting featured 3 KPWHRI researchers in a panel workshop on “Conducting Pragmatic Trials of Interventions to Improve Care for Substance Use in Medical Settings”:

  • Associate Investigator Joe Glass, PhD, MSW, presented on early results from the Digital Therapeutics for Opioids and Other Substance User Disorders (DIGITS) Trial, which piloted implementation of the reset/reset-O substance abuse app in primary care.
  • Assistant Investigator Gwen Lapham, PhD, MHP, MSW, shared insights from the Center for Accelerating Care Transformation’s Adolescent Integrated Mental Health pilot and the unique challenges faced when implementing substance use screening into routine care for teens.
  • Collaborative Scientist Paige Wartko, PhD, MPH, discussed the Primary Care Opioid Use Disorders Treatment (PROUD) Trial, highlighting lessons learned from this cluster-randomized trial of opioid use disorder treatment in primary care.